Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Panel weighs tighter review, citation rules for therapeutic cannabis oversight board
Summary
Lawmakers heard competing testimony on SB 400, which would require the Therapeutic Cannabis Medical Oversight Board to conduct scheduled reviews of qualifying medical conditions and include literature citations with recommendations. Supporters said the change would provide clinicians and patients with clearer evidence; the oversight board said mandatory frequent systematic reviews could be onerous and unnecessary.
The committee heard hours of expert testimony on SB 400, a bill that would change statute to require the Therapeutic Cannabis Medical Oversight Board (TCMOB) to perform scheduled reviews of qualifying medical conditions and to include citations supporting any recommendation.
Sponsor representative Grotta introduced the measure on behalf of Senator Gannon. Sue Hamola, who spoke early for the bill, said the change would create an explicit timeline and better documentation for the board’s recommendations: "This bill actually seeks to amend the RSA 1 26 x to have the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
